US – Federal: The FDA has come in for some strong criticism after its first court-ordered update revealed the agency did not expect to finish reviewing the remaining PMTA applications until at least June 2023. ...
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.
LATEST ALERTS
